A Prospective Natural History Study in Uveal Melanoma
This study is building a comprehensive database, like a medical diary, to track people with uveal melanoma, a type of eye cancer. Doctors want to understand the full journey of this disease, from when it's first found, through different treatments, and if it comes back elsewhere in the body. This record will involve information from eye cancer specialists and medical oncologists working together across different hospitals. By collecting this detailed information over time, researchers hope to gain crucial insights into how uveal melanoma behaves. This knowledge is vital for developing new and more effective treatments in the future and ultimately improving the lives of those affected by this rare condition.
एक नजर में
यह अध्ययन किस बारे में है?
Uveal melanoma is a rare type of cancer that starts in the eye. While it's the most common cancer inside the eye, it's very rare overall. This study aims to create a comprehensive record, called a registry, of people living with uveal melanoma. Think of it as a detailed, ongoing medical diary for many patients, following their journey from diagnosis through treatment and any re-occurrence.
Currently, there isn't one big, ongoing study collecting all this important information in a consistent way. This new registry is designed to fill that gap. Doctors from different specialist areas, including eye cancer specialists (ophthalmologic oncologists) and cancer specialists (medical oncologists), often work together to care for patients with uveal melanoma. This study brings these experts together to make sure that the registry captures a complete picture of the disease's progression.
The main goal is to understand the 'natural history' of uveal melanoma – how it typically develops, what kind of treatments are used at different stages, and how patients respond over time. By gathering this detailed information from many patients, researchers hope to learn more about the disease. This knowledge is absolutely vital for designing future studies and developing new, more effective therapies to improve treatment and outcomes for people with uveal melanoma.
मुख्य निष्कर्ष
- This study creates a vital database for uveal melanoma, a rare eye cancer.
- It collects medical information to understand the disease's full journey.
- The goal is to improve future treatments and patient care.
- Participation involves sharing your routine medical data, not new interventions.
- Your data's privacy is rigorously protected.
- You can withdraw from the study at any time without impacting your care.
कौन पात्र हो सकता है?
To be part of this study, you would need to have been diagnosed with uveal melanoma. This registry is open to adults aged 18 years and older; there is no upper age limit.
Participation usually involves giving your written permission (consent) for your medical information to be included in the registry. In some cases, your hospital's review board (IRB/ethics committee) might allow your information to be used anonymously if you can't provide written consent, or for information already collected from your past medical records.
There are no specific reasons that would prevent you from taking part, other than not having a diagnosis of uveal melanoma or not being able to provide consent (unless a waiver is in place).
क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?
यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.
- Have I been diagnosed with uveal melanoma?
- क्या मैं 18 वर्ष का या उससे अधिक उम्र का हूँ?
- Am I able to provide consent for my medical information to be used?
- Has my doctor mentioned this registry as part of my ongoing care?
भागीदारी में क्या शामिल है?
Taking part in this study is different from a typical clinical trial where you might receive experimental medication. This study is observational, meaning it mostly involves collecting information from your routine medical care for uveal melanoma. You wouldn't need to attend extra visits or have additional assessments beyond what your doctors already recommend.
The study would involve your medical information, such as your diagnosis, treatments you receive, how you respond to those treatments, and any follow-up care, being collected and added to the registry by your healthcare team. This process continues throughout your journey with uveal melanoma, following the disease's natural course. You would not receive any specific medication or intervention as part of this study itself.
संभावित जोखिम और लाभ
Locations (17)
- मैसाचुसेट्स जनरल अस्पतालसत्यापित पोस्टकोडबोस्टन, संयुक्त राज्य अमेरिका
- मेमोरियल स्लोन केटरिंग कैंसर केंद्रसत्यापित पोस्टकोडन्यूयॉर्क, संयुक्त राज्य अमेरिका
- Thomas Jefferson University Hospitalसत्यापित पोस्टकोडफिलाडेल्फिया, संयुक्त राज्य अमेरिका
- एमडी एंडरसन कैंसर केंद्रसत्यापित पोस्टकोडह्यूस्टन, संयुक्त राज्य अमेरिका
- रॉयल एडिलेड अस्पतालसत्यापित पोस्टकोडएडिलेड, ऑस्ट्रेलिया
- Chatswood Eye Specialistsसत्यापित पोस्टकोडChatswood, Australia
- Royal Victorian Eve and Ear Hospitalसत्यापित पोस्टकोडEast Melbourne, Australia
- Western Eye Specialistsसत्यापित पोस्टकोडMaribyrnong, Australia
- Pennington Eye Clinicसत्यापित पोस्टकोडNorth Adelaide, Australia
- Perth Retinaसत्यापित पोस्टकोडSubiaco, Australia
- Dr. Conway Private Roomsसत्यापित पोस्टकोडसिडनी, ऑस्ट्रेलिया
- St. Vincent's Hospitalसत्यापित पोस्टकोडसिडनी, ऑस्ट्रेलिया
सामान्य प्रश्न
What is uveal melanoma?
Uveal melanoma is a rare type of cancer that develops in the uvea, the middle layer of your eye.
Will I receive new treatments in this study?
No, this study is about collecting information from your standard care, not providing new treatments.
Who will have access to my medical information?
Only authorized researchers and medical staff involved in the study will have access, and your data will be kept confidential.
How long will I be part of this study?
The study aims to follow the full journey of uveal melanoma, so your information would be collected over an extended period as part of your ongoing care.
अगर मैं अपना मन बदल लूँ तो क्या मैं भाग लेना बंद कर सकता हूँ?
Yes, you can withdraw your consent to participate at any time, and it will not affect your medical care.
और अधिक जानने के लिए कैसे पता करें
किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.
चर्चा
समुदाय चर्चा
हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.